0,1,2,3,4,5
agreement  with,,the  conventional  sequencing  of  each,,,5' UTR regions of HRV and HEV genomes and the capabil-
"Table 2: Identification of HEV serotypes using microarray, de novo sequencing, and in silico model of de novo sequence results.",,,,,
Strain,VP1 typing#,Array,de novo sequence,in silico model,Accession number
1,CAVA16,CAVA16,ND,ND,
2,EV71,EV71,ND,ND,
3,CAVA21,CAVA21,ND,ND,
4,CAVB4,CAVB4,ND,ND,
5,EV3,EV3,EV3(95%),CAV16,EU870485
6,EV68,EV68,EV68(99%),EV68,EU870491
7,EV69,EV69,ND,ND,
8,EV70,EV70,ND,ND,
9,EV75,EV75,EV75(99%),EV75,EU870493
10,EV4,EV6,EV6(93%),EV4,EU870488
11,EV5,CAVB3,CAVB3(94%),CAVB3,EU870489
12,EV30,HEVB,EV30(95%),EV30,EU870486
13,CAVA14,HEVA/B,ND,ND,
14,EV1,HEVB,ND,ND,
15,EV6,HEVB,EV74(94%),HEVB,EU870490
16,EV7,HEVB,EV30(95%),HEVB,EU870492
17,EV11,HEVB,ND,ND,
18,EV18,HEVB,EV74(93%),HEVB,EU870483
29,EV29,HEVB,EV80(85%),HEVB,EU870484
20,CAVA20,HEVC,ND,ND,
21,CAVA24,HEVC,ND,ND,
22,CAVA9,HEVB,ND,ND,
23,CAVB1,HEVB,ND,ND,
24,CAVB2,HEVB,ND,ND,
25,CAVB3,HEVB,ND,ND,
26,EV25,HEVB,ND,ND,
27,EV33,HEVB,CAVA12(91%),HEVB,EU870487
28,EV9,HEVB,ND,ND,
